Product Introduction | RTSM · Randomization and Trial Supply Management System

Source: EClinCloud. Author: EClinCloud.

With advances in technology and national regulatory requirements and encouragement, the shift toward electronic clinical research has become the future trend for clinical trials. Web-based randomization and drug supply management systems are being used in a growing number of clinical trials, and randomization and control, as fundamental principles of clinical trials, are widely applied in efficacy and safety evaluations. An RTSM system is of great significance for improving both the efficiency and quality of clinical trials.
What Is EClinCloud RTSM?
The full name of the EClinCloud RTSM system is Randomization and Trial Supply Management, a next-generation randomization and trial supply management system designed for multicenter subject randomization and drug supply management. It can effectively manage multicenter clinical trials with large numbers of subjects and address pain points in drug dispensing and drug management.
The EClinCloud RTSM system integrates functional modules for randomization schemes, treatment regimens, subject management, and drug supply plan management. It supports a range of complex randomization schemes and trial designs, providing investigators with an efficient, secure, and convenient system tool for randomized trials and drug management.
What Are the Features of the EClinCloud RTSM System?
Includes multiple built-in randomization algorithms and blinding settings, supports multi-segment block configurations and real-time capture of stratification factors, and accurately reproduces allocation tables
When a user uploads an allocation table, the system rapidly reverse-engineers the scheme configuration based on the file contents
Four-in-one treatment regimen design that supports multi-visit dosing and multi-regimen allocation, as well as data capture and multi-factor configuration for drug dosage factors
Supports subject management operations within the subject management module, including drug dispensing, unblinding, data export, and open-label treatment
Supports full-lifecycle drug control across bidirectional dimensions, with configurable smart plan comparison and early-warning alert functions
What Are the Advantages of EClinCloud RTSM?
01
Effectively Curbs Human Intervention to Safeguard Study Safety and Authenticity
The system incorporates multiple built-in randomization algorithms and blinding settings to ensure balance across treatment groups, effectively curb human intervention, and enhance the objectivity, safety, authenticity, and credibility of the study.


02
Clean, User-Friendly Interface with Clear Workflow Logic
The system's functional modules are designed to align with real-world workflows, offering convenient configuration and rapid responsiveness to protocol requirements.

03
Closed-Loop Drug Management Integrating Supply and Control
Provides full-lifecycle drug control across bidirectional dimensions, supporting smart plan comparison and early-warning alerts.

04
Adaptable to Multiple Application Scenarios with High Flexibility
Supports inter-system integration and data interoperability, while also supporting subject drug dispensing operations and status management when used standalone.

05
Robust Data Security
Granular user permission configuration down to the module and function level; a comprehensive data security system and SOP system certification; and thorough technical solutions for data security across both production and R&D environments.

What Services Does EClinCloud Provide?
EClinCloud is a technology company focused on clinical research and development. It provides an integrated, interoperable, all-in-one clinical trial cloud platform (including technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, ophthalmology, and others). Combining cutting-edge technology with life-science data, it builds a globally leading "patient-centric" SaaS cloud platform for clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs and medical devices, and benefit countless patients.



